Open sidebar
Focus
CureVac
Business & Markets
|
Reuters
Pfizer, BioNTech Seek to Revoke CureVac’s Patent Infringement Claims
Sep 05, 2022
|
Reuters
Sep 05
|
Economy
|
Reuters
BioNTech, Pfizer Sue CureVac in US Over COVID-19 Vaccine Patent Claims
Jul 28, 2022
|
Reuters
Jul 28
|
Companies
|
Reuters
CureVac Files Patent Lawsuit in Germany Against BioNTech
Jul 06, 2022
|
Reuters
Jul 06
|
Vaccines & Safety
|
Reuters
CureVac COVID-19 Vaccine Records 48 Percent Efficacy in Final Trial Readout
Jul 01, 2021
|
Reuters
Jul 01
|